scholarly journals Workshop of European task force on medication‐related osteonecrosis of the jaw—Current challenges

Oral Diseases ◽  
2019 ◽  
Vol 25 (7) ◽  
pp. 1815-1821 ◽  
Author(s):  
Morten Schiodt ◽  
Sven Otto ◽  
Stefano Fedele ◽  
Alberto Bedogni ◽  
Ourania Nicolatou‐Galitis ◽  
...  
Keyword(s):  
Task Force ◽  
Osteonecrosis Of The Jaw ◽  
European Task

scholarly journals Dental management in Oncology patient: osteonecrosis related osteonecrosis of the Jaw (MRONJ)

2020 ◽  
Vol 4 (1) ◽  
pp. 01-02
Author(s):  
Picardo Noemi
Keyword(s):  
Task Force ◽  
Health Assessment ◽  
Osteonecrosis Of The Jaw ◽  
Oncology Patient ◽  
Stomatognathic System ◽  
Oncological Patients ◽  
Dental Management ◽  
Antiresorptive Drugs ◽  
Antiangiogenic Drugs

It is essential that oncological patients treated with antiresorptives or antiangiogenic drugs diagnosed Medication Related Osteonecrosis of the Jaw (MRONJ) must be treated in an interdisciplinary fashion. The patient’s stomatognathic system should be examined preventatively prior to the initiation of antiresorptive drugs in order to avoid pathological buccal manifestations, following the same healthcare clinical protocols used for patients receiving head and neck radiotherapy. Additionally, patients should be informed of the precautions to be taken, including regular dental appointments for oral health assessment. The risk of developing MRONJ should be evaluated according to the type of antiresorptives or antiangiogenic drugs administered and treatment duration. In the case of MRONJ, its fundamental characteristic is positioned in the biochemical particularity of the pharmacokinetic expression of antiresorptive drugs, reversibly (DS) or irreversibly (BPs) inhibiting the functionality of the osteoclast. Therefore, the consideration of invading bone tissue as little as possible and performing resective therapies in cases of systemic infectious spread follows, since its long-term resolution would not be effective because the drug (BPs) has frank accumulation at a distance, a characteristic used by treating doctors and it would not have clinical relevance to suggest its suspension. According to the recommendations of AAOMS; Task Force and AOCMF coincide with the sharing of consensus on minimally invasive manipulations once the necrotic foci have been installed and the preventive attitude prevails of eliminating all septic foci prophylactically before starting therapy with antiresorptive drugs. There are positions with a trend more committed to frank bone manipulation with the aim of evacuating the infectious problem and other more conservative positions in order not to expand drug necrosis volumetrically due to bone accumulation of BPs or DS.

scholarly journals Task Force on Design and Analysis in Oral Health Research: Medication-Related Osteonecrosis of the Jaw

2018 ◽  
Vol 3 (3) ◽  
pp. 222-225 ◽  
Author(s):  
S. Ruggiero ◽  
D. Saxena ◽  
S. Tetradis ◽  
T. Aghaloo ◽  
E. Ioannidou
Keyword(s):  
Oral Health ◽  
Knowledge Transfer ◽  
Health Research ◽  
Patient Management ◽  
Task Force ◽  
Osteonecrosis Of The Jaw ◽  
Clinical Protocols

Knowledge Transfer Statement: This article discusses the proceedings of the conference organized by the Task Force on Design and Analysis in Oral Health Research on the understanding of the translational evidence on the etiology and pathogenesis of medication-related osteonecrosis of the jaw as well as the clinical protocols on patient management.

scholarly journals Portuguese version of the EUROPEP questionnaire: contributions to the psychometric validation

2016 ◽  
Vol 50 (0) ◽  
Author(s):  
Hugo Roque ◽  
Ana Veloso ◽  
Pedro L Ferreira
Keyword(s):  
General Practice ◽  
Internal Consistency ◽  
Task Force ◽  
Family Health ◽  
Data Matrix ◽  
Patient Evaluation ◽  
Portuguese Version ◽  
European Task ◽  
General Practice Care ◽  
Practice Care

ABSTRACT OBJECTIVE To assess the construct validity and reliability of the Portuguese version of the European Task Force on Patient Evaluation of General Practice Care questionnaire. METHODS We applied the Portuguese version of the European Task Force on Patient Evaluation of General Practice Care to 392 users of 20 Family Health Units from the North of Portugal. The validity of the construct was evaluated by exploratory factor analysis, with the Principal Axis Factoring method, by orthogonal rotation (varimax procedure), by the Kaiser normalization criteria (eigenvalue ≥ 1). The factorability of the data matrix was verified by the Kaiser-Meyer-Olkin and Bartlett’s sphericity test. We estimated the reliability by the indicator of internal consistency Cronbach’s alpha. To analyze the correlations between satisfaction and loyalty, we used the Pearson correlations. The predictor effect of satisfaction on loyalty was analyzed by simple linear regression. RESULTS Satisfaction presented five robust and well individualized dimensions – medical care, nursing care, clinical secretariat services, accessibility, and organization of services – with alpha values between 0.86 and 0.97, good levels of internal consistency. The loyalty showed alpha value of 0.72, considered a reasonable internal consistency. The satisfaction was predictive of loyalty. CONCLUSIONS The Portuguese European Task Force on Patient Evaluation of General Practice Care questionnaire is a robust and reliable instrument to measure the satisfaction and loyalty of users of the Family Health Units.

scholarly journals ICRF-code benchmark activity in the framework of the European task-force on integrated Tokamak Modelling

2014 ◽  
Author(s):  
R. Bilato ◽  
D. Coster ◽  
R. Dumont ◽  
T. Johnson ◽  
H.-J. Klingshirn ◽  
...  
Keyword(s):  
Task Force ◽  
European Task

Assessment of lipid-lowering treatment in Bulgaria — The CEPHEUS study

Open Medicine ◽  
2013 ◽  
Vol 8 (5) ◽  
pp. 627-637 ◽  
Author(s):  
Nina Gotcheva ◽  
Dimitar Raev ◽  
Elina Trendafilova ◽  
Arman Postadzhiyan ◽  
Nikolay Runev ◽  
...  
Keyword(s):  
Task Force ◽  
Primary Objective ◽  
Lipid Lowering ◽  
Risk Category ◽  
Cross Sectional Survey ◽  
Cross Sectional ◽  
History Of ◽  
Therapy Compliance ◽  
European Task ◽  
Dose Change

AbstractThis is a multicenter cross-sectional survey of 2,500 Bulgarian adult patients taking lipid-lowering drugs (LLDs) for at least 3 months with no dose change for a minimum of 6 weeks. The primary objective was to establish the proportion of patients who are on LDL-C target, according to the Fourth Joint European Task Force (FJETF) guidelines. The secondary objectives were to define the proportion of patients at target: according to the 2001 National Cholesterol Education Program Adult Treatment Panel (NCEP ATP) III and the 2004 NCEP ATP III guidelines. The patients’ demographics, current LLD treatment, cardiovascular medical history were recorded. Next the lipid profile, glucose level and HbA1c were obtained from these patients. The investigators and patients completed questionnaires related to the LLD therapy. Gender, BMI, history of CHD, therapy compliance, risk category, lack of patient’s awareness of LDL-C targets were all studied as determinants of the undertreatment. Despite the satisfactory awareness of guidelines for management of hypercholesterolaemia, their implementation in clinical practice is still poor. Only 43.10% of patients reached the FJETF-recommended LDL-C goal, 45.24% achieved the 2001 NCEP ATP III recommended LDL-C goal, and only 21.51% — reached the 2004 NCEP ATP III recommended target. Males, CHD patients and those who were aware of LDL-C targets had more chance of reaching their desired LDL-C target.

Sign in / Sign up

Export Citation Format

Share Document